Cited by 1,360Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 179 of the 181 references it cites were found in a registry or an index.

Polycystic ovary syndrome

Norman, Robert J, Dewailly, Didier, Legro, Richard S, Hickey, Theresa E·2007·The Lancet

DOI 10.1016/s0140-6736(07)61345-2

Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61345-2

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citation
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121

Show all 181 references

Research works printed but not linked: 5

Azziz, 2006, Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess Society guideline, J Clin Endocrinol Metab, 91, 4237, 10.1210/jc.2006-0178 · DOI · Paper page
Legro, 1999, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, J Clin Endocrinol Metab, 84, 165
Legro, 2006, Pregnancy in polycystic ovary syndrome (PPCOS) baseline characteristics: effect of race and ethnicity on the PCOS phenotype, J Soc Gynecol Investig, 13, 268a
van Vloten, 2002, The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea, Cutis, 69, 2
Hughes, 2000, Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome, Cochrane Database Syst Rev, 2

Sorted by citations

Items 301–400 of 1,000

Endometrial progesterone receptor isoforms in women with polycystic ovary syndrome.
Hu, M., Li, J., Zhang, Y., Li, X., Brännström, M., Shao, R., & Billig, H. (2018) · Europe PMC (PubMed Central) · Cited by 48
CYP19A1 gene expression in patients with polycystic ovarian syndrome
Panghiyangani, R., Soeharso, P., Andrijono, Suryandari, D. A., Wiweko, B., Kurniati, M., & Pujianto, D. A. (2020) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_142_18 · Cited by 50
Evaluation of endometrial immune status of polycystic ovary syndrome
Liu, S., Hong, L., Mo, M., Xiao, S., Chen, C., Li, Y., Lian, R., Wang, X., Cai, S., Diao, L., et al. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103282 · Cited by 47
Infographics and the Elaboration Likelihood Model (ELM): Differences between Visual and Textual Health Messages
Lam, C., Huang, Z., & Shen, L. (2022) · Journal of Health Communication · doi:10.1080/10810730.2022.2157909 · Cited by 47
High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysis
Sun, Y., Wu, Z., Wei, L. S., Liu, C., Zhu, S., & Tang, S. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1056140 · Cited by 47
Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model
Kang, X., Jia, L., & Shen, X. (2015) · BioMed Research International · doi:10.1155/2015/943694 · Cited by 47
Evidence for Decreased Expression of ADAMTS-1 Associated With Impaired Oocyte Quality in PCOS Patients
Xiao, S., Li, Y., Li, T., Chen, M., Xu, Y., Wen, Y., & Zhou, C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4177 · Cited by 47
Temporal window in which exposure to estradiol permanently modifies ovarian function causing polycystic ovary morphology in rats
Cruz, G., Barra, R., González, D., Sotomayor‐Zárate, R., & Lara, H. E. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1060 · Cited by 47
Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome
Xi, W., Yang, Y.-K., Mao, H. Z., Zhao, X., Liu, M., & Fu, S. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0214-2 · Cited by 47
Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
dos Reis, G. V. O. P., Gontijo, N. A., Rodrigues, K. F., Alves, M. T., Ferreira, C. N., & Gomes, K. B. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13250 · Cited by 47
Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects
Ruan, X., Kubba, A., Aguilar, A., & Mueck, A. O. (2017) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2017.1317735 · Cited by 47
Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort
de Wilde, M. A., Eising, J. B., Gunning, M. N., Koster, M. P. H., Evelein, A. M. V., Dalmeijer, G. W., Uiterwaal, C. S. P. M., Eijkemans, M. J. C., van der Ent, C. K., Meijboom, F. J., et al. (2018) · Reproductive Sciences · doi:10.1177/1933719117749761 · Cited by 47
Obese and non-obese polycystic ovarian syndrome: Comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene
Gainder, S., Sachdeva, G., Suri, V., Sachdeva, N. K., & Chopra, S. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_637_18 · Cited by 47
The Prevalence and Impact of Polycystic Ovary Syndrome in Recurrent Miscarriage: A Retrospective Cohort Study and Meta-Analysis
Mayrhofer, D., Hager, M., Walch, K., Ghobrial, S., Rogenhofer, N. N., Marculescu, R., Seemann, R., & Ott, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092700 · Cited by 50
The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis
Yin, W., Huang, C.-C., Chen, Y.-R., Yu, D., Jin, M., & Feng, C. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01065-9 · Cited by 46
Baicalein improves the symptoms of polycystic ovary syndrome by mitigating oxidative stress and ferroptosis in the ovary and gravid placenta
Li, Y., Peng, Y., Yang, Y., Shi, T., Liu, R., Luan, Y., & Yin, C. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155423 · Cited by 46
Per- and Polyfluoroalkyl Substances (PFAS) Affect Female Reproductive Health: Epidemiological Evidence and Underlying Mechanisms
Qu, R., Wang, J., Li, X., Zhang, Y., Yin, T., & Yang, P. (2024) · Toxics · doi:10.3390/toxics12090678 · Cited by 49
Elevated matrix metalloproteinase-8 in saliva and serum in polycystic ovary syndrome and association with gingival inflammation
Akcalı, A., Bostancı, N., Özçaka, Ö., Ceyhan, B. Ö., Gümüş, P., Tervahartiala, T. I., Husu, H., Buduneli, N., Sorsa, T. A., & Belibasakis, G. N. (2015) · Innate Immunity · doi:10.1177/1753425915572172 · Cited by 46
Androgen/androgen receptor pathway regulates expression of the genes for cyclooxygenase-2 and amphiregulin in periovulatory granulosa cells
Yazawa, T., Kawabe, S., Kanno, M., Mizutani, T., Imamichi, Y., Ju, Y., Matsumura, T., Yamazaki, Y., Usami, Y., Kuribayashi, M., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.004 · Cited by 46
Milk consumption: aggravating factor of acne and promoter of chronic diseases of Western societies
Melnik, B. C. (2009) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2009.07019.x · Cited by 46
Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome
Dumont, A., Robin, G., & Dewailly, D. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000445 · Cited by 45
Self-citation
Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review
Carvalho, L. M. L., dos Reis, F. M., Cândido, A. L., Nunes, F. F. C., Ferreira, C. N., & Gomes, K. B. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0026 · Cited by 48
Alterations of Sphingolipid Metabolism in Different Types of Polycystic Ovary Syndrome
Li, J., Xie, L., Song, J., Yau, L., Mi, J., Zhang, C., Wu, W., Lai, M.-H., Jiang, Z., Wang, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38944-6 · Cited by 46
Maternal androgen excess induces cardiac hypertrophy and left ventricular dysfunction in female mice offspring
Manti, M., Fornes, R., Pironti, G., Haworth, S. M., Zhuge, Z., Benrick, A., Carlström, M., Andersson, D. C., & Stener‐Victorin, E. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz180 · Cited by 47
Fatty infiltration of the pancreas: a systematic concept analysis
Mahyoub, M. A., Elhoumed, M., Maqul, A. H., Almezgagi, M., Abbas, M. A., Jiao, Y., Wang, J., Alnaggar, M., Zhao, P., & He, S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1227188 · Cited by 43
Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents
Jungheim, E. S., & Odibo, A. O. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.077 · Cited by 47
Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome
Sung, Y., Oh, J. Y., Chung, H., & Lee, H. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.027 · Cited by 45
Diagnosis of adolescent polycystic ovary syndrome
Hardy, T., & Norman, R. J. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.011 · Cited by 45
Self-citation
Estrogen and progesterone receptor subtype expression in granulosa cells from women with polycystic ovary syndrome
Artimani, T., Saidijam, M., Aflatoonian, R., Amiri, I., Ashrafi, M., Shabab, N., Mohammadpour, N., & Mehdizadeh, M. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2014.1001733 · Cited by 45
Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome
Karaköse, M., Demircan, K., Tutal, E., Demirci, T., Arslan, M., Şahi̇n, M., Celik, H. T., Kazancı, F. H., Karakaya, J., Çakal, E., et al. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0472-2 · Cited by 45
Mercury leads to features of polycystic ovary syndrome in rats
Merlo, E., Schereider, I. R. G., Simões, M. R., Vassallo, D. V., & Graceli, J. B. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.05.006 · Cited by 48
Association between Biomarkers of Low-grade Inflammation and Sex Hormones in Women with Polycystic Ovary Syndrome
Hatziagelaki, E. E., Pergialiotis, V., Kannenberg, J. M., Trakakis, E., Tsiavou, A., Markgraf, D. F., Carstensen‐Kirberg, M., Pacini, G., Roden, M., Dimitriadis, G., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0992-9114 · Cited by 46
A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity?
Alanbay, İ., Ercan, C. M., Sakıncı, M., Çoksüer, H., Ozturk, M., & Tapan, S. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2425-0 · Cited by 45
Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome
Panidis, D., Τζιόμαλος, Κ., Μacut, D., Delkos, D., Betsas, G., Misichronis, G., & Katsikis, I. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.041 · Cited by 44
Analysis of mitochondrial DNA sequence variants in patients with polycystic ovary syndrome
Zhuo, G., Ding, Y., Feng, G., Yu, L., & Jiang, Y. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2358-7 · Cited by 44
Síndrome do ovário policístico: abordagem dermatológica
de Moura, H. H. G., Costa, D. L. M., Bagatin, E., Sodré, C. T., & Manela‐Azulay, M. (2011) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962011000100015 · Cited by 44
Per- and polyfluoroalkyl substances (PFASs) – New endocrine disruptors in polar bears (Ursus maritimus)?
Pedersen, K. E., Letcher, R. J., Sonne, C., Dietz, R., & Styrishave, B. (2016) · Environment International · doi:10.1016/j.envint.2016.07.015 · Cited by 47
Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
Panico, A., Messina, G., Lupoli, G., Lupoli, R., Cacciapuoti, M., Moscatelli, F., Esposito, T., Villano, I., Valenzano, A. A., Monda, V., et al. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s119180 · Cited by 44
Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome
Zhang, Z., Hong, Y., Chen, M., Tan, N., Liu, S., Nie, X., & Zhou, W. (2020) · Metabolomics · doi:10.1007/s11306-020-1642-y · Cited by 44
The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review
Zhai, J., Li, Z., Zhou, Y., & Yang, X. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103490 · Cited by 44
The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome
Panidis, D., Tziomalos, K., Papadakis, E., Chatzis, P., Kandaraki, E. A., Tsourdi, E. A., & Katsikis, I. (2014) · Clinical Endocrinology · doi:10.1111/cen.12305 · Cited by 43
Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study
Sayyah-Melli, M., Alizadeh, M., Pourafkari, N., Ouladsahebmadarek, E., Jafari-Shobeiri, M., Abbassi, J., Kazemi-Shishvan, M. A., & Sedaghat, K. (2015) · Journal of Caring Sciences · doi:10.15171/jcs.2015.023 · Cited by 43
Serum Pigment Epithelium-Derived Factor Is Elevated in Women with Polycystic Ovary Syndrome and Correlates with Insulin Resistance
Yang, S., Li, Q., Zhong, L., Song, Y., Tian, B., Cheng, Q., 青华, Xia, W., Luo, M., & Mei, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2140 · Cited by 43
Androgens as double-edged swords: Induction and suppression of follicular development
Pan, J., Zhang, J., Ke, Z.-H., Wang, F., Barry, J. A., Hardiman, P., & Qu, F. (2015) · HORMONES · doi:10.14310/horm.2002.1580 · Cited by 41
Investigation of Therapeutic Effects of Erdosteine on Polycystic Ovary Syndrome in a Rat Model
Karateke, A., Dokuyucu, R., Doğan, H., Özgür, T., Taş, Z. A., Tutuk, O., Ağtürk, G., & Tümer, C. (2018) · Medical Principles and Practice · doi:10.1159/000494300 · Cited by 43
Protein Lysine Acetylation in Ovarian Granulosa Cells Affects Metabolic Homeostasis and Clinical Presentations of Women With Polycystic Ovary Syndrome
Min, Z., Long, X., Zhao, H., Zhen, X., Li, R., Li, M., Fan, Y., Yu, Y., Zhao, Y., & Qiao, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.567028 · Cited by 46
Maternal obesity is a potential source of error in mid‐trimester ultrasound estimation of gestational age
Simić, M., Amer‐Wåhlin, I., Maršál, K., & Källén, K. (2009) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.7502 · Cited by 42
microRNA in Human Reproduction
Eisenberg, I., Kotaja, N., Goldman‐Wohl, D., & Imbar, T. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_18 · Cited by 42
Treatment of Androgen Excess in Adolescent Girls: Ethinylestradiol-Cyproteroneacetate Versus Low-Dose Pioglitazone-Flutamide-Metformin
Ibáñez, L., Díaz, M., Sebastiani, G., Sánchez‐Infantes, D., Salvador, C., López‐Bermejo, A., & de Zegher, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1671 · Cited by 42
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome
Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.133 · Cited by 41
Importance of lipid accumulation product index as a marker of CVD risk in PCOS women
Nascimento, J. X. P. T., Chein, M. B. D. C., de Sousa, R. M. L., Ferreira, A. D. S., Navarro, P. A., & Brito, L. M. O. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0061-y · Cited by 41
Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome
Panidis, D., Τζιόμαλος, Κ., Chatzis, P., Papadakis, E. P., Delkos, D., Tsourdi, E. A., Kandaraki, E., & Katsikis, I. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0655 · Cited by 41
Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical–biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study
Reyes-Muñoz, E., Ortega-González, C., Martínez-Cruz, N., Arce-Sánchez, L., Estrada‐Gutiérrez, G., Morán, C., Sánchez-Serrano, A. P., Higareda-Sánchez, R., & la Jara-Díaz, J. F. D. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012107 · Cited by 41
The effects of 6-Gingerol on reproductive improvement, liver functioning and Cyclooxygenase-2 gene expression in estradiol valerate – Induced polycystic ovary syndrome in Wistar rats
Pournaderi, P. S., Yaghmaei, P., Khodaei, H., Noormohammadi, Z., & Hejazi, S. H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.057 · Cited by 41
Xiao-Yao-San, a Chinese Medicine Formula, Ameliorates Chronic Unpredictable Mild Stress Induced Polycystic Ovary in Rat
Sun, H., Li, Q., Liu, Y., Wei, X., Pan, C., Fan, J., & Han, J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00729 · Cited by 41
Comparing pregnancy, childbirth, and neonatal outcomes in women with different phenotypes of polycystic ovary syndrome and healthy women: a prospective cohort study
Foroozanfard, F., Asemi, Z., Bazarganipour, F., Taghavi, S. A., Allan, H. T., & Aramesh, S. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1631278 · Cited by 41
The Source of Polycystic Ovarian Syndrome
Raperport, C., & Homburg, R. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119871467 · Cited by 43
Cardiovascular Properties of the Androgen‐Induced PCOS Model in Rats: The Role of Oxidative Stress
Joksimović, J., Sretenovic, J. Z., Jovic, N., Rudic, J., Zivkovic, V. I., Srejovic, I. M., Mihajlović, K., Draginic, N., Andjic, M. M., Milinković, M., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8862878 · Cited by 41
Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome
Hirshfeld‐Cytron, J., Barnes, R. B., Ehrmann, D. A., Caruso, A., Mortensen, M., & Rosenfield, R. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2248 · Cited by 41
Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients
Xi, W., Gong, F., & Lu, G. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9726-x · Cited by 41
Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone–choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women
El‐Shal, A. S., Zidan, H. E., Rashad, N. M., Abdelaziz, A. M., & Harira, M. M. (2015) · IUBMB Life · doi:10.1002/iub.1457 · Cited by 39
Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?
Işık, H., Aynıoğlu, Ö., Tımur, H., Şahbaz, A., Harma, M., Can, M., Güven, B., Alptekin, H., & Köktürk, F. (2016) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2016.06.002 · Cited by 40
Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome
Jové, M., Pradas, I., Naudí, A., Rovira‐Llopis, S., Bañuls, C., Rocha, M., Portero‐Otín, M., Hernández‐Mijares, A., Víctor, V. M., & Pamplona, R. (2017) · Oncotarget · doi:10.18632/oncotarget.23393 · Cited by 40
Prenatal androgen induced lean PCOS impairs mitochondria and mRNA profiles in oocytes
Chappell, N. R., Zhou, B., Schutt, A. K., Gibbons, W. E., & Blesson, C. S. (2020) · Endocrine Connections · doi:10.1530/ec-19-0553 · Cited by 40
Sonographic Measurement of Mesenteric Fat Predicts Presence of Fatty Liver among Subjects with Polycystic Ovary Syndrome
Ma, R. C. W., Liu, K. H., Lam, P. M., Cheung, L. P., Tam, W. H., Ko, G. T. C., Chan, M. H. M., Ho, C. S., Lam, C. W. K., Chu, C. W., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1608 · Cited by 40
The Effect of Chromium Supplementation on Polycystic Ovary Syndrome in Adolescents
Amr, N. H., & Abdel-Rahim, H. E. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.05.005 · Cited by 39
Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
Wang, F., Yu, B., Yang, W., Liu, J., Lü, J., & Xia, X. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-15 · Cited by 39
Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome
Almawi, W. Y., Gammoh, E., Malalla, Z. H. A., & Al-Madhi, S. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165636 · Cited by 39
Serum AMH Level to Predict the Hyper Response in Women with PCOS and Non-PCOS Undergoing Controlled Ovarian Stimulation in ART
Vembu, R., & Reddy, S. (2017) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_15_16 · Cited by 39
Altered expression of the kisspeptin/KISS1R and neurokinin B/NK3R systems in mural granulosa and cumulus cells of patients with polycystic ovarian syndrome
Blasco, V., Pinto, F. M., Fernández‐Atutxa, A., Prados, N., Tena‐Sempere, M., Sánchez, M. F., & Candenas, L. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1338-7 · Cited by 38
Effects of electroacupuncture on anxiety and depression in unmarried patients with polycystic ovarian syndrome: secondary analysis of a pilot randomised controlled trial
Wang, Z., Dong, H., Wáng, Q., Zhang, L., Wu, X., Zhou, Z., Li, Y., & Huang, D. (2019) · Acupuncture in Medicine · doi:10.1136/acupmed-2017-011615 · Cited by 39
Assessment of sexual and reproductive health knowledge and awareness among single unmarried women living in Lebanon: a cross-sectional study
Hemdanieh, M., Ftouni, L., AlJardali, B., Ftouni, R., Rawas, C., Ghotmi, M., Zein, M. H. E., Ghazi, S., & Malas, S. (2021) · Reproductive Health · doi:10.1186/s12978-021-01079-x · Cited by 39
The effectiveness and safety of liraglutide in treating overweight/obese patients with polycystic ovary syndrome: a meta-analysis
Ge, J. J., Wang, D., Song, W., Shen, S., & Ge, W. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01666-6 · Cited by 39
An artificial intelligence-based decision support system for early diagnosis of polycystic ovaries syndrome
Nsugbe, E. (2023) · Healthcare Analytics · doi:10.1016/j.health.2023.100164 · Cited by 39
Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic Strategy
Salehi, S., Allahverdy, J., Pourjafar, H., Sarabandi, K., & Jafari, S. M. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10223-5 · Cited by 45
Expression and localisation of c-kit and KITL in the adult human ovary
Tuck, A., Robker, R. L., Norman, R. J., Tilley, W. D., & Hickey, T. E. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0159-x · Cited by 38
Self-citation
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment
Amato, M. C., Guarnotta, V., Forti, D., Donatelli, M., Dolcimascolo, S., & Giordano, C. S. D. S. (2013) · Human Reproduction · doi:10.1093/humrep/det105 · Cited by 39
Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABAA receptor sensitivity to allopregnanolone
Hedström, H., Bäckström, T. C., Bixo, M., Nyberg, S., Wang, M., Gideonsson, I., & Türkmen, Ş. (2015) · Clinical Endocrinology · doi:10.1111/cen.12809 · Cited by 38
Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
Jacewicz‐Święcka, M., & Kowalska, I. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3054 · Cited by 39
Association of luteinizing hormone/choriogonadotropin receptor gene polymorphisms with polycystic ovary syndrome risk: a meta-analysis
Zou, J., Wu, D., Liu, Y., & Tan, S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1498834 · Cited by 38
A review of IVF in PCOS patients at risk of ovarian hyperstimulation syndrome
Thakre, N., & Homburg, R. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1631797 · Cited by 38
Ovarian dysfunction and the premenopausal origins of coronary heart disease
Kaplan, J. R., & Manuck, S. B. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31815eb18e · Cited by 38
Diet, physical exercise and Orlistat administration increase serum Anti-Müllerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)
Vosnakis, C., Georgopoulos, N. A., Rousso, D., Mavromatidis, G., Katsikis, I., Roupas, N. D., Mamali, I., & Panidis, D. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.736557 · Cited by 48
Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome
Su, Y.-N., Wang, M., Yang, J.-P., Wu, X.-L., Xia, M., Bao, M., Ding, Y., Feng, Q., & Fu, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1122709 · Cited by 37
Correlations of Insulin Resistance and Serum Testosterone Levels with LH:FSH Ratio and Oxidative Stress in Women with Functional Ovarian Hyperandrogenism
Suresh, S., & Vijayakumar, T. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0447-z · Cited by 37
What do we know about metabolic syndrome in adolescents with PCOS?
Cırık, D. A., & Dilbaz, B. (2014) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2014.95776 · Cited by 38
A novel method of extraction of bamboo seed oil (Bambusa bambos Druce) and its promising effect on metabolic symptoms of experimentally induced polycystic ovarian disease
Soumya, V., Muzib, Y. I., & Venkatesh, P. (2016) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.178833 · Cited by 37
LINE1 CpG-DNA Hypomethylation in Granulosa Cells and Blood Leukocytes Is Associated With PCOS and Related Traits
Sagvekar, P., Mangoli, V. S., Desai, S. K., Patil, A. D., & Mukherjee, S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2645 · Cited by 37
Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non‐obese Saudi women
Daghestani, M. H. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12527 · Cited by 37
Validity of the association between periodontitis and female infertility conditions: a concise review
Machado, V., Lopes, J. P., Patrão, M., Botelho, J., Proença, L., & Mendes, J. J. (2020) · Reproduction · doi:10.1530/rep-20-0176 · Cited by 37
MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 1
Li, Y., Yao, N., Gao, Y., Wang, Y., Bai, L., Xu, J., & Wang, H. (2021) · Bioengineered · doi:10.1080/21655979.2021.1987125 · Cited by 38
Adipocytes-Derived Extracellular Vesicle-miR-26b Promotes Apoptosis of Cumulus Cells and Induces Polycystic Ovary Syndrome
Zhou, G., Gu, Y., Zhou, F., Zhang, H., Zhang, M., Zhang, G., Wu, L., Hua, K., & Ding, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.789939 · Cited by 37
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials
Fadlalmola, H. A., Elhusein, A. M., Al‐Sayaghi, K. M., Albadrani, M. S., Swamy, D. S. V., Mamanao, D. M., El-Amin, E. I., Ibrahim, S. E., & Abbas, S. M. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.44.134.32404 · Cited by 38
miRNA-592 is downregulated and may target LHCGR in polycystic ovary syndrome patients
Jin, S., Luo, S., & Li, S. (2015) · Reproductive Biology · doi:10.1016/j.repbio.2015.10.005 · Cited by 36
Metformin improves endothelial function and carotid intima media thickness in patients with PCOS
Kaya, M. G., Yıldırım, S., Çalapkorur, B., Akpek, M., Ünlühızarcı, K., & Keleştimur, F. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1006188 · Cited by 36
Exposure to Tobacco Smoke in Utero and Subsequent Plasma Lipids, ApoB, and CRP among Adult Women in the MoBa Cohort
Cupul‐Uicab, L. A., Skjærven, R., Haug, K., Travlos, G. S., Wilson, R. E., Eggesbø, M. Å., Hoppin, J. A., Whitworth, K. W., & Longnecker, M. P. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104563 · Cited by 36
The Circadian Variation in Anti-Müllerian Hormone in Patients with Polycystic Ovary Syndrome Differs Significantly from Normally Ovulating Women
Bungum, L. J., Franssohn, F., Bungum, M., Humaidan, P., & Giwercman, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068223 · Cited by 35
Vascular function in the diagnostic categories of polycystic ovary syndrome
Moran, L., Cameron, J. D., Strauss, B. J., & Teede, H. J. (2011) · Human Reproduction · doi:10.1093/humrep/der159 · Cited by 36
Effect of Non‐Surgical Periodontal Therapy Along With Myo‐Inositol on High‐Sensitivity C‐Reactive Protein and Insulin Resistance in Women With Polycystic Ovary Syndrome and Chronic Periodontitis: A Randomized Controlled Trial
Deepti, Tewari, S., Narula, S. C., Singhal, S. R., & Sharma, R. K. (2017) · Journal of Periodontology · doi:10.1902/jop.2017.170121 · Cited by 39
Investigation of the uterine structural changes in the experimental model with polycystic ovary syndrome and effects of vitamin D treatment: An ultrastructural and immunohistochemical study
Kuyucu, Y., Çelik, L. S., Kendirlinan, Ö., Tap, Ö., & Mete, U. (2018) · Reproductive Biology · doi:10.1016/j.repbio.2018.01.002 · Cited by 36

Authors: Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E.
Affiliations: The University of Adelaide (AU)
Centre Hospitalier Universitaire de Lille (FR)
Pennsylvania State University (US)
Corresponding author: Hickey, Theresa E
ORCID: Norman, Robert J
Dewailly, Didier
Legro, Richard S
Hickey, Theresa E
Venue: The Lancet
Publisher: Elsevier BV
Published: 2007-08
Volume: 370
Issue: 9588
Pages: 685-697
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(07)61345-2
OpenAlex: W2499178053
Cited by: 1,360
References: 181
Citations by year: 2026: 43 · 2025: 61 · 2024: 100 · 2023: 100 · 2022: 101 · 2021: 105 · 2020: 94 · 2019: 86 · 2018: 86 · 2017: 74 · 2016: 78 · 2015: 70 · 2014: 62 · 2013: 52 · 2012: 60
FWCI: 6.99
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, hyperandrogenism, insulin resistance, menstrual disorders, infertility, hirsutism, acne, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, diagnostic criteria, chronic anovulation, polycystic ovary, genetic susceptibility, lifestyle factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks